What is the typical cost of Acalabrutinib?
The average retail price for Acalabrutinib, sold under the brand name Calquence, is approximately $18,225 for a 30-day supply of 100 mg capsules [1]. This price can vary depending on the dosage and pharmacy [1].
How can patients reduce the cost of Acalabrutinib?
Patients may be able to reduce their out-of-pocket expenses through manufacturer-sponsored programs. The AstraZeneca Oncology Sản phẩm Support Program may offer financial assistance to eligible patients [1].
What is Acalabrutinib used to treat?
Acalabrutinib is a prescription medication used to treat adults with certain types of cancer, including mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) [1].
When does Acalabrutinib's patent expire?
Patent expiration timelines for medications like Acalabrutinib are complex and can involve multiple patents. Information regarding specific patent expiry dates for Acalabrutinib can be found on resources like DrugPatentWatch.com [2].
Are there generic alternatives to Acalabrutinib?
As of late 2023, generic versions of Acalabrutinib were not yet available. Typically, generic alternatives emerge after the expiration of key patents and regulatory approvals [2].
How does Acalabrutinib work?
Acalabrutinib is a type of drug called a Bruton's tyrosine kinase (BTK) inhibitor. It works by blocking the action of BTK, a protein that plays a role in the growth and survival of certain cancer cells [1].
What are the potential side effects of Acalabrutinib?
Common side effects of Acalabrutinib can include decreased white blood cell counts (neutropenia), anemia, low platelet counts (thrombocytopenia), bleeding, diarrhea, muscle pain (myalgia), bruising, and rash [1]. Serious side effects can also occur [1].
---
1. Calquence (acalabrutinib) capsules. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/210509s025lbl.pdf
2. DrugPatentWatch.com. https://www.drugpatentwatch.com/